Co-Authors
This is a "connection" page, showing publications co-authored by Robert Evans and Stephen Walker.
Connection Strength
3.256
-
Evans RJ, Overholt T, Colaco M, Walker SJ. Injection location does not impact botulinum toxin A efficacy in interstitial cystitis/bladder pain syndrome patients. Can J Urol. 2020 02; 27(1):10125-10129.
Score: 0.713
-
Walker SJ, Plair A, Hemal K, Langefeld CD, Matthews C, Badlani G, Zambon J, Heath H, Evans RJ. Bladder Hydrodistention Does Not Result in a Significant Change in Bladder Capacity for Interstitial Cystitis/Bladder Pain Syndrome Patients. Urology. 2019 Oct; 132:81-86.
Score: 0.685
-
Walker SJ, Zambon J, Andersson KE, Langefeld CD, Matthews CA, Badlani G, Bowman H, Evans RJ. Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome. J Urol. 2017 08; 198(2):369-375.
Score: 0.580
-
Xu R, Schachar J, Evans RJ, Matthews CA, Badlani G, Walker SJ. Hydrodistention does not alter bladder gene expression profiles in patients with non-Hunner lesion interstitial cystitis/bladder pain syndrome. Neurourol Urodyn. 2021 May 04.
Score: 0.194
-
Overholt TL, Evans RJ, Lessey BA, Matthews CA, Hines KN, Badlani G, Walker SJ. Non-bladder centric interstitial cystitis/bladder pain syndrome phenotype is significantly associated with co-occurring endometriosis. Can J Urol. 2020 06; 27(3):10257-10262.
Score: 0.182
-
Overholt TL, Ross C, Evans RJ, Walker SJ. Pulsed Electromagnetic Field Therapy as a Complementary Alternative for Chronic Pelvic Pain Management in an Interstitial Cystitis/Bladder Pain Syndrome Patient. Case Rep Urol. 2019; 2019:5767568.
Score: 0.177
-
Schachar JS, Evans RJ, Parks GE, Zambon J, Badlani G, Walker SJ. Histological evidence supports low anesthetic bladder capacity as a marker of a bladder-centric disease subtype in interstitial cystitis/bladder pain syndrome. Int Urogynecol J. 2019 11; 30(11):1863-1870.
Score: 0.171
-
Matthews CA, Deveshwar SP, Evans RJ, Badlani G, Walker SJ. Small fiber polyneuropathy as a potential therapeutic target in interstitial cystitis/bladder pain syndrome. Int Urogynecol J. 2019 11; 30(11):1817-1820.
Score: 0.171
-
Matthews CA, Eschenroeder A, Badlani G, Evans R, Walker SJ. Evaluation of the efficacy of postmortem human bladder tissue as a normal comparator for case-controlled gene expression studies in urology. Neurourol Urodyn. 2017 04; 36(4):1076-1080.
Score: 0.140
-
Walker SJ, Colaco M, Koslov DS, Keys T, Evans RJ, Badlani GH, Andersson KE. Transcriptome analysis of bladder biopsy from interstitial cystitis/bladder pain syndrome patients. Genom Data. 2014 Dec; 2:366-8.
Score: 0.124
-
Colaco M, Koslov DS, Keys T, Evans RJ, Badlani GH, Andersson KE, Walker SJ. Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome. J Urol. 2014 Oct; 192(4):1123-9.
Score: 0.120